SHIELD THERAPEUTICS PLC
Ownership & governance
Executives 5Directors 6Avg age 64Avg tenure 4.3y
KL
Karl Lundström
Chief Executive Officer
Age 64Since 2024-07-23Profile →
+10
Executives5
Board of directors6
PL
Peter Llewellyn-Davies→
Director/Board Member
Age 68Since 2016-01-31
HH
Hans-Peter Hasler→
Chairman
Age 70Since 2020-06-17
CS
Christian Schweiger→
Director/Board Member
Age 59Since 2020-06-25
ML
Maria Lacerca-Allen→
Director/Board Member
Age 59Since 2021-05-09
KL
Karl Lundström→
Director/Board Member
Age 64Since 2021-05-09
RW
Rudolf Widmann→
Director/Board Member
—Since 2024-07-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| AOP Health International Management AG | 54.53 % | 582,608,592 |
| UBS Asset Management Switzerland AG | 6.064 % | 64,794,000 |
| Hargreaves Lansdown Asset Management Ltd. | 5.81 % | 62,072,631 |
| NESTLÉ S.A. | 5.38 % | 57,480,914 |
| Premier Fund Managers Ltd. | 2.808 % | 30,000,000 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Hans-Peter Hasler | Chairman | 2020-06-17 | - |
| Karl Lundström | Chief Executive Officer | 2024-07-23 | - |
| Paul Spoors | Director of Finance/CFO | 2023-10-19 | - |
| Christian Schweiger | Director/Board Member | 2020-06-25 | - |
| Karl Lundström | Director/Board Member | 2021-05-09 | - |
| Maria Lacerca-Allen | Director/Board Member | 2021-05-09 | - |
| Peter Llewellyn-Davies | Director/Board Member | 2016-01-31 | - |
| Rudolf Widmann | Director/Board Member | 2024-07-02 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 16.67Range 12–23Analysts 3
12Mean 16.6723
- Buy 3
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.